Cyabra, Inc. (CYAB) executive buys shares and Series A/B warrants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cyabra Chief Product Officer Yossef Daar increased his stake through a private placement on July 10, 2026. He purchased 53,650 common shares at $0.435 per share from the company and acquired Series A and Series B warrants, each series covering 53,650 shares with exercise prices of $0.45 and $0.50 per share. The warrants become exercisable only after requisite stockholder approval. Following these transactions, Daar directly holds 894,199 common shares and the newly purchased warrants, which expire twelve months and five years, respectively, after their initial exercise dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 107,300 shares ($50,968)
Net Buy
3 txns
Insider
Daar Yossef
Role
Chief Product Officer
Bought
107,300 shs ($51K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock Warrants (right to buy) | 53,650 | $0.45 | $24K |
| Purchase | Common Stock Warrants (right to buy) | 53,650 | $0.50 | $27K |
| Grant/Award | Common Stock | 53,650 | $0.435 | $23K |
Holdings After Transaction:
Common Stock Warrants (right to buy) — 53,650 shares (Direct);
Common Stock — 894,199 shares (Direct)
Footnotes (1)
- On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share. The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement. The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval. The Series B Warrants expire twelve (12) months following the initial exercise date. The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement. The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval. The Series A Warrants expire five (5) years following the initial exercise date.
Key Figures
Common stock purchased: 53,650 shares
Common stock purchase price: $0.435 per share
Series A warrant exercise price: $0.45 per share
+3 more
6 metrics
Common stock purchased
53,650 shares
Bought from Cyabra in a private placement on July 10, 2026
Common stock purchase price
$0.435 per share
Price paid for 53,650 common shares in the private placement
Series A warrant exercise price
$0.45 per share
Series A warrants to purchase up to 53,650 shares of Common Stock
Series B warrant exercise price
$0.50 per share
Series B warrants to purchase up to 53,650 shares of Common Stock
Shares held after transaction
894,199 shares
Direct Cyabra common stock holdings following July 10, 2026 activity
Warrants held after transaction
107,300 warrants
Total Series A and B warrants owned after the reported purchases
Key Terms
Private Placement, Series B Warrants, Series A Warrants, requisite stockholder approval
4 terms
Private Placement financial
"purchased 53,650 shares of common stock ... in a private placement transaction"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Series B Warrants financial
"purchased Series B warrants to purchase up to 53,650 shares of Common Stock"
Series B warrants are contracts issued alongside a company's Series B financing that give the holder the right to buy a set number of shares at a fixed price within a specified time. For investors, they matter because they can provide leveraged upside if the company grows, or they can dilute existing shareholders when exercised—like a coupon promising a future share at a known price that can add value or change ownership stakes.
Series A Warrants financial
"purchased Series A warrants to purchase up to 53,650 shares of Common Stock"
Series A warrants are financial tools that give the holder the right to buy shares of a company at a specific price within a certain period. They are often issued alongside investments to provide additional potential profit if the company's value increases. For investors, they can offer a chance to benefit from future growth without committing immediate capital to buying shares.
requisite stockholder approval regulatory
"will become exercisable upon the receipt of the requisite stockholder approval"
FAQ
What insider transactions did CYAB's Chief Product Officer report on July 10, 2026?
On July 10, 2026, Cyabra Chief Product Officer Yossef Daar purchased 53,650 common shares at $0.435 each in a private placement and acquired Series A and Series B warrants covering a combined 107,300 shares of common stock.
At what prices did the CYAB insider buy stock and warrants?
Yossef Daar bought 53,650 common shares at $0.435 per share. He also acquired Series A warrants with a $0.45 exercise price and Series B warrants with a $0.50 exercise price, each series covering 53,650 underlying shares.
When do CYAB's Series A and Series B warrants become exercisable and when do they expire?
Both Series A and Series B warrants become exercisable only after Cyabra receives the requisite stockholder approval. The Series B warrants expire twelve months after their initial exercise date, while the Series A warrants expire five years after their initial exercise date.
Was the CYAB insider transaction part of a private placement with the company?
Yes. The disclosure states that Yossef Daar purchased 53,650 common shares and related Series A and Series B warrants directly from Cyabra in a private placement transaction, rather than through open‑market purchases for the stock component.